Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan
Authors:
- Gordon W. MoeGMGordon W. Moe
- Jean L. RouleauJRJean L. Rouleau
- Lynne CharbonneauLCLynne Charbonneau
- Guy ProulxGPGuy Proulx
- J.MAlcolm O. ArnoldJAJ.MAlcolm O. Arnold
- Christian HallCHChristian Hall
- Jacques de ChamplainJCJacques de Champlain
- Aiala BarrABAiala Barr
- Pierre SiroisPSPierre Sirois
- Milton PackerMPMilton Packer
- Candian PROFILE investigatorsCICandian PROFILE investigators
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 139 (4) , 587-595
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).Circulation, 1993
- Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failureJACC, 1993
- Flosequinan, a new vasodilator: Systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failureJACC, 1992
- Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failureJACC, 1992
- Flosequinan: A vasodilator with positive inotropic activityAmerican Heart Journal, 1991
- Chronic vasodilator therapy with flosequinan in congestive heart failureClinical Cardiology, 1990
- Effect of flosequinan on exercise capacity and symptoms in severe heart failure.Heart, 1989
- Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ, 1988
- Cumulative Hemodynamic Response to Short-Term Treatment with Flosequinan (BTS 49465), a New Direct-Acting Vasodilator Drug, in Severe Chronic Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1988
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987